Gastric Cancer

Article	Citations
The putative pleiotropic functions of meprin β in gastric cancer	1032
Metabolic reprogramming as a key regulator in Helicobacter pylori-infected gastric cancer	104
Clinicopathological significance of microsatellite instability and immune escape mechanism in patients with gastric solid-type poorly differentiated adenocarcinoma	66
Digital histopathological images of biopsy predict response to neoadjuvant chemotherapy for locally advanced gastric cancer	65
Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis	62
Methodological and reporting considerations in real-world anamarin studies of gastric cancer-related cachexia	55
Risk prediction model for gastric cancer within 5 years in healthy Korean adults	54
Decorin as a key marker of desmoplastic cancer-associated fibroblasts mediating first-line immune checkpoint blockade resistance in metastatic gastric cancer	54
DNA mismatch repair deficiency and outcomes of patients with locally advanced gastric cancer treated with preoperative docetaxel, oxaliplatin, and S-1 plus surgery and postoperative S-1 or surgery plu	51
Dose–response association between cigarette smoking and gastric cancer risk: a systematic review and meta-analysis	50
An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study	41
Predicting chemotherapy responsiveness in gastric cancer through machine learning analysis of genome, immune, and neutrophil signatures	40
The combination of gene hyperamplification and PD-L1 expression as a biomarker for the clinical benefit of tislelizumab in gastric/gastroesophageal junction adenocarcinoma	37
Outcomes after gastrectomy according to the Gastrectomy Complications Consensus Group (GCCG) in the Dutch Upper GI Cancer Audit (DUCA)	33
LncRNA expression signature identified using genome-wide transcriptomic profiling to predict lymph node metastasis in patients with stage T1 and T2 gastric cancer	33
Comment on: Statin use in relation to long-term survival after gastrectomy for gastric adenocarcinoma: a Swedish population-based cohort study	33
Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study	32
Type 2 diabetes in patients undergoing gastric cancer surgery: areas requiring disease-specific glycemic management	32
Minimally invasive versus open completion total gastrectomy for remnant gastric cancer: a nationwide propensity score-matched analysis	32
Novel affibody molecules targeting the AXL extracellular structural domain for molecular imaging and targeted therapy of gastric cancer	31
Risk factors and clinical outcomes associated with leptomeningeal carcinomatosis in gastric cancer	30
Prognostic significance of tertiary lymphoid structures in gastric neuroendocrine carcinoma with association to delta-like ligand 3 and neuroendocrine expressions	29
Correction: International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape	29
International consensus on the management of metastatic gastric cancer: step by step in the foggy landscape	29
FERMT2 drives anoikis resistance and peritoneal metastasis by enhancing extracellular matrix deposition in gastric cancer	28

Serum TFF2 as a more reliable biomarker for gastric cancer and early gastric cancer: a cross-sectional population-based study	28
Long-term quality of life, financial toxicity, and decision regret following therapeutic and prophylactic gastrectomy for cancer	27
Antibody–drug conjugates in gastric cancer: from molecular landscape to clinical strategies	27
FBXW7 regulates the sensitivity of imatinib in gastrointestinal stromal tumors by targeting MCL1	26
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry	25
Soluble PD-L1 as a diagnostic and prognostic biomarker in resectable gastric cancer patients	25
Nivolumab plus chemotherapy in patients with HER2-negative, previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: 3-year follow-up of the ATTRACTION-4 ra	24
Volume of hepatoid component and intratumor M2 macrophages predict prognosis in patients with hepatoid adenocarcinoma of the stomach	24
Global prevalence of claudin 18 isoform 2 in tumors of patients with locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma	23
A functional NKILA variant (rs2273534) drives genetic susceptibility and oncogenic progression in gastric cancer via the miR-4424/OAS2 pathway	23
Effect of preoperative chemotherapy on the histopathological classification of gastric cancer	23
Optimal treatment strategy after first-line induction therapy in advanced HER2-positive oeso-gastric adenocarcinoma—a retrospective, international, multicentric AGEO study	22
Potential therapeutic targets discovery by transcriptome analysis of an in vitro human gastric signet ring carcinoma model	22
Prognostic value of post-operative serum procalcitonin in gastric adenocarcinoma patients undergoing radical gastrectomy: propensity score matching analysis of extended cohort from a prospective bi-ce	22
Development and application of deep learning-based diagnostics for pathologic diagnosis of gastric endoscopic submucosal dissection specimens	21
Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences	21
Time-sequential prediction of postoperative complications after gastric cancer surgery using machine learning: a multicenter cohort study	21
Angiotensin receptor blocker and angiotensin-converting enzyme inhibitor use and survival in gastric cancer patients: a Finnish nationwide cohort study	20
Effect of single-shot intrathecal morphine versus continuous epidural analgesia on length of stay after gastrectomy for cancer: a retrospective cohort study	20
Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancer	20
Numerous lesions of gastric adenocarcinoma of fundic-gland and fundic gland-mucosa type in a patient	20
Histone H4K8 lactylation modulated immunosuppressive properties by promoting FAP transcription and ECM remodeling	20
SUSD2+ cancer-associated fibroblasts in gastric cancer mediate the effect of immunosuppression and predict overall survival and the effectiveness of neoadjuvant immunotherapy	20
Artificial intelligence–based anatomical recognition improves surgeon decision-making during robotic gastrectomy	20
Suppression of galectin-4 attenuates peritoneal metastasis of poorly differentiated gastric cancer cells	20
Lipolysis-stimulated lipoprotein receptor promote lipid uptake and fatty acid oxidation in gastric cancer	19
International Delphi consensus guidelines for follow-up after prophylactic total gastrectomy: the Life after Prophylactic Total Gastrectomy (LAP-TG) study	19
A systematic review on the effectiveness of robot-assisted minimally invasive gastrectomy	19
Simple clinical parameters to identify sarcopenia 1 year after gastrectomy for gastric cancer	19
Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice	19
The RNA-binding protein YTHDF3 affects gastric cancer cell migration and response to paclitaxel by regulating EZRIN	19
Multi-omics sequencing of gastroesophageal junction adenocarcinoma reveals prognosis-relevant key factors and a novel immunogenomic classification	18
Impact of adjuvant therapy on outcomes of cancer of the stomach and gastroesophageal junction in the real-world	18
Japanese gastric cancer treatment guidelines 2025 (7th edition)	18
Factors associated with the efficacy of first-line nivolumab plus chemotherapy in advanced gastric cancer patients with deficient mismatch repair	18
Comparative study of the short-term outcomes of gastric cancer surgery between Japanese Gastric cancer association-certified and non-certified institutions: a retrospective cohort analysis using a nat	18
Correction to: Effectiveness of second-look endoscopy after gastric endoscopic submucosal dissection in patients taking antithrombotic agents: a multicenter propensity score matching analysis	18
Clinical advantages of robotic gastrectomy for gastric cancer over conventional laparoscopic approach: a retrospective cohort study using a nationwide registry database in Japan	18
Hospital variation in surgical outcomes for gastric cancer: the impact of case-mix and treatment across a global cohort	17
Impact of histologically poorly cohesive phenotype as a prognostic factor in patients with pStage II/III gastric cancer undergoing adjuvant chemotherapy	17
Investigating the role of inflammatory cytokines in mediating the effect of gut microbiota on gastrointestinal cancers: a mendelian randomization study	17
Clinical outcomes of Epstein–Barr virus (EBV)-associated metastatic and locally advanced unresectable gastric cancers (GCs) in patients receiving first-line fluoropyrimidine and platinum (FP) doublet	16
Intraperitoneal paclitaxel plus intravenous fluorouracil, leucovorin, oxaliplatin (FOLFOX) and nivolumab for gastric cancer with peritoneal metastasis: results from the IPLUS Phase II study	16
Impact of perioperative fluorouracil, leucovorin, oxaliplatin, and docetaxel delivery on postoperative survival in locally advanced oesophagogastric adenocarcinoma	16
Thromboembolic events in patients who received adjuvant chemotherapy for gastric cancer: a single-center retrospective study	15
TMEM205 induces TAM/M2 polarization to promote cisplatin resistance in gastric cancer	15
Ethnic-specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations	15
Appetite-preserving gastrectomy (APG) for esophagogastric junction cancer: preserving the residual stomach as an endocrine organ	15
ATF4-mediated circTDRD3 promotes gastric cancer cell proliferation and metastasis by regulating the miR-891b/ITGA2 axis and AKT signaling pathway	14
Leptomeningeal carcinomatosis in gastric cancer: A Review	14

Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis	14
Low positivity rate of fibroblast growth factor receptor 2b is associated with heterogeneous expression in gastric cancer	14
Health-related quality-of-life outcomes with regorafenib in advanced gastric and esophagogastric junction cancer: results from the INTEGRATE trials	14
Predictive value of homologous recombination-related gene mutations in survival outcomes of first-line nivolumab plus chemotherapy for gastric cancer	14
N6-methyladenosine-modified MIB1 promotes stemness properties and peritoneal metastasis of gastric cancer cells by ubiquitinating DDX3X	13
Correction: Safety, survival outcomes, and prognostic factors in conversion surgery for advanced gastric cancer: a sub-analysis of Japanese patients in the CONVO-GC-1 study	13
Reply to the letter to the editor regarding “Appetite-preserving gastrectomy (APG) for esophagogastric junction cancer: preserving the residual stomach as an endocrine organ”	13
Letter to the editor: 5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric	13
The clinical importance of the host anti-tumour reaction patterns in regional tumour draining lymph nodes in patients with locally advanced resectable gastric cancer: a systematic review and meta-anal	13
Minimum resection length to ensure a pathologically negative distal margin and a larger remnant stomach for esophagogastric junction cancer	13
Comparison of clinicopathological features of gastric carcinoma in autoimmune gastritis with and without Helicobacter pylori infection	13
Reply to: Letter to editor on the article “Choice of PD-L1 immunohistochemistry assay influences clinical eligibility for gastric cancer immunotherapy”	13
Clinical epidemiology of the endoscopic, laparoscopic, and surgical resection of malignant gastric tumors in Japan, 2014–2021: a retrospective study using open data from a national claims database	13
A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001–2013)	13
Limitations of the cox proportional hazards model and alternative approaches in metachronous recurrence research	12
A phase II trial of ramucirumab and docetaxel as second-line treatment for patients with advanced gastric cancer (HGCSG 1903)	12
Elucidating molecular mechanisms and therapeutic synergy: irreversible HER2-TKI plus T-Dxd for enhanced anti-HER2 treatment of gastric cancer	12
Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer	12
Safety and feasibility of single-incision laparoscopic distal gastrectomy in overweight and obese gastric cancer patients: a propensity score-matched analysis	12
SOX combined with sintilimab versus SOX alone in the perioperative management of locally advanced gastric cancer: a propensity score–matched analysis	12
Development of adenovirus-based oncolytic virus to induce EBV lytic reactivation	12
Comment on:“Gastric equivalent of the ‘Holy Plane’ to standardize the surgical concept of stomach cancer to mesogastric excision: updating Jamieson and Dobson’s historic schema,” Gastric cancer, 2021	12
Circulating tumor DNA predicts recurrence and survival in patients with resectable gastric and gastroesophageal junction cancer	12
Biological and targeting differences between the rare KRAS A146T and canonical KRAS mutants in gastric cancer models	12
Morbidity and quality of life of totally laparoscopic versus laparoscopy-assisted distal gastrectomy for early gastric cancer: a multi-center prospective randomized controlled trial (CKLASS01)	12
Clinical relevance of PD-1 positive CD8 T-cells in gastric cancer	11
Impact of body composition on survival of PD-1/PD-L1-treated metastatic gastro-esophageal junction/gastric cancer	11
Circulating tumor DNA predicts outcome in metastatic gastroesophageal cancer	11
Exercise–nutrition prehabilitation attenuates lean body mass loss before gastrectomy: a randomized controlled trial	11
Pharmacokinetic and tissue distribution advantages of intraperitoneal oxaliplatin over systemic delivery: a swine model comparison of PIPAC and HPIPAC	11
Early endpoints of a randomized phase II trial of preoperative chemotherapy with S-1/CDDP with or without trastuzumab followed by surgery for HER2-positive resectable gastric or esophagogastric juncti	11
A multi-institutional study to evaluate the feasibility of next-generation sequencing and genomic analysis using formalin-fixed, paraffin-embedded biopsies of gastric cancer	11
Interruption of imatinib in advanced gastrointestinal stromal tumor after prolonged imatinib maintenance in the absence of gross tumor lesions	10
Acknowledgment to Reviewers	10
Neoadjuvant chemotherapy in relation to long-term mortality in individuals cured of gastric adenocarcinoma	10
Cardiovascular and thromboembolic outcomes with immune checkpoint inhibitors in gastroesophageal cancer: a propensity score-matched cohort study	10
SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib	10
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer	10
IL-1β derived from mixed-polarized macrophages activates fibroblasts and synergistically forms a cancer-promoting microenvironment	10
Definitive 24 Gy radiotherapy for stage IE gastric MALT lymphoma: large-scale validation of an optimal dose with reduced acute toxicity	10
Failure of evaluation on ABC classification for gastric cancer screening	10
Gallbladder edema as a clue to zolbetuximab-associated protein-losing enteropathy in gastric cancer: a case report	10
CDKN2A somatic copy number amplification in normal tissues surrounding gastric carcinoma reduces cancer metastasis risk in droplet digital PCR analysis	10
Q-TWiST analysis of first-line nivolumab plus chemotherapy versus chemotherapy in patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma from CheckMate 6	9
Safety and feasibility of robot-assisted remote radical gastrectomy for gastric cancer based on 5G communication technology (FUTURE-04): a prospective, single-arm clinical trial	9
Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition)	9
Impact of early economic activity loss on all-cause mortality in gastric cancer survivors following curative treatment: a nationwide study in Korea	9
Oncological similarities between large type 3 and type 4 tumors in patients with resectable gastric cancer: a propensity score-matched analysis of a multi-institutional dataset	9
Concordance of microsatellite instability and mismatch repair status in paired biopsies and surgical specimens of resectable gastroesophageal adenocarcinoma: time for a call to action	9
Nishi memorial award in gastric cancer	9
Gastric cancer secondary prevention in dyspeptic patients	9
Clinical impact of primary and secondary KIT mutations on the efficacy of molecular-targeted therapies in gastrointestinal stromal tumors	9
A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy for type 4 or large type 3 gastric cancer (OGSG 1402)	9
Racial disparities of gastric cancer in the USA: an overview of epidemiology, global screening guidelines, and targeted screening in a heterogeneous population	9
IL-17A promotes Helicobacter pylori-induced gastric carcinogenesis via interactions with IL-17RC	9
Recurrence of gastric cancer caused by implantation of tumor cells after percutaneous transesophageal gastrostomy	9
Importance of duodenal stump reinforcement to prevent stump leakage after gastrectomy: a large-scale multicenter retrospective study (KSCC DELICATE study)	9
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS	8
COPS5 inhibition synergizes with the antitumor effect of trastuzumab by PTEN upregulation in HER2-amplified gastric cancer	8
Prognostic implications of tissue-based homologous recombination deficiency in metastatic gastric cancer treated with immune checkpoint inhibitor plus chemotherapy	8
The relationship between the gastric cancer microbiome and clinicopathological factors: a metagenomic investigation from the 100,000 genomes project and The Cancer Genome Atlas	8
Limitations of Helicobacter pylori-attributable gastric cancer estimates in Albania	8
Comment on “Comparative effectiveness of sodium-glucose cotransporter-2 inhibitors for new-onset gastric cancer and gastric diseases in patients with type 2 diabetes mellitus: a population-based cohor	8
Identification of CD66c as a potential target in gastroesophageal junction cancer for antibody–drug conjugate development	8
Metachronous primary gastric cancer after endoscopic resection in patients with esophageal squamous cell carcinoma	8
Tackling similarities and differences in global practice guidelines for gastric cancer: a review on the latest Taiwan guidelines with Asia-Pacific, European and US guidelines	7
Long-term adjuvant therapy for high-risk gastrointestinal stromal tumors in the real world	7
Heterogeneity of predictive biomarker expression in gastric and esophago-gastric junction carcinoma with peritoneal dissemination	7
Combined loss of CDH1 and downstream regulatory sequences drive early-onset diffuse gastric cancer and increase penetrance of hereditary diffuse gastric cancer	7
Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells	7
Efficacy and safety of trastuzumab biosimilar CT-P6 plus SOX or CapeOX in HER2-positive advanced gastric cancer: a multicenter phase II KSCC-TROX study	7
Neoadjuvant camrelizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastroesophageal junction adenocarcinoma: a single-arm, phase 2 trial	7
LOC101929709 promotes gastric cancer progression by aiding LIN28B to stabilize c-MYC mRNA	7
Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy	7
Comparison of perioperative outcomes between bipolar sealing, ultrasonic shears and a hybrid device during laparoscopic gastrectomy for early gastric cancer: a prospective, multicenter, randomized stu	7
Chromosomal copy number amplification-driven Linc01711 contributes to gastric cancer progression through histone modification-mediated reprogramming of cholesterol metabolism	7
Risk factors of perforation in gastric stromal tumors during endoscopic resection: a retrospective case–control study	6
Adjuvant treatment for locally advanced gastric cancer: an Asian perspective	6
Correction: Real-world effectiveness and safety of trastuzumab-deruxtecan in Japanese patients with HER2-positive advanced gastric cancer (EN-DEAVOR study)	6
Burden of gastric cancer attributable to Helicobacter pylori in 27 countries from seven geographic regions in 2022	6

National guidelines for gastric cancer: redundant or needed?	6
Molecular profile of poorly cohesive gastric carcinoma with special reference to survival	6
Textbook outcome in gastrectomy: useful metric or moving target? A scoping review	6
Clinical impact of gastrectomy in surgically proven stage IV gastric cancers: retrospective analysis from Korean multicenter dataset (PASS-META)	6
Feasibility study of cap-assisted endoscopic mucosal resection for gastric adenocarcinoma of fundic gland type	6
Development and validation of a machine learning model for predicting immune checkpoint inhibitor efficacy in advanced gastric cancer using dynamic changes in peripheral blood clinlabomics data: a ret	6
Gastric tubular adenocarcinoma with diffuse neutrophils infiltrating: characteristics and probable treatment strategy	6
A phase Ib study of photoimmunotherapy with ASP-1929 in combination with nivolumab for advanced gastric cancer (GE-PIT, EPOC1901)	6
Circulating hormones and risk of gastric cancer by subsite in three cohort studies	6
Racial/ethnic and geographic differences in second primary cancers in stomach cancer survivors: a comparative study of U.S. and South Korea	6
Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019	6
Helicobacter pylori-naïve status is associated with poor prognosis and aggressive pathological features in undifferentiated-type gastric cancer: a multi-center retrospective cohort study	6
Clinicopathologic features and prognostic impact of late recurrence after gastrectomy for gastric cancer	6
Targeting the OXNAD1–PTGS2 axis with resveratrol overcomes ferroptosis Inhibition and reverses 5-FU resistance in gastric cancer	6
Early detection of gastric cancer via multiplex blood assay targeting CfDNA methylation signatures	6
Nishi memorial award in gastric cancer	6
Acknowledgment to Reviewers	6
Preferred neoadjuvant therapy for gastric and gastroesophageal junction adenocarcinoma: a systematic review and network meta-analysis	6
Oncological impact of unexpected horizontal tumor spread in gastric cancer that requires total gastrectomy	6
The Magic Flute is a Singspiel, not an opera? My thoughts about the German, Austrian and Swiss Guidelines for Systemic Treatment of Gastric Cancer	5
PD-L1 IHC testing: issues with interchangeability evidence based on laboratory-developed assays of unknown analytical performance	5
Deep learning predicts resistance to neoadjuvant chemotherapy for locally advanced gastric cancer: a multicenter study	5
Mapping the genetic landscape of hereditary diffuse-type gastric cancer progression	5
The occurrence, progression and development of four types of gastric mucosal atrophic lesions and their histopathological characteristics	5
Artificial intelligence in gastric cancer risk assessment: expanding horizons for personalized surveillance in corpus atrophic gastritis	5
Superior lymph node harvest by fluorescent lymphography during minimally invasive gastrectomy for gastric cancer patients with high body mass index	5
Hospital-based gastric cancer outcomes in the United States (2003–2022): racial and regional disparities	5
The molecular profile of gastric intraepithelial foveolar type neoplasia based on somatic copy number alterations and multiple mutation analysis	5
Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type	5
Relationship between antithrombotic drugs and postoperative outcomes in patients with gastric cancer after gastrectomy: a propensity matching analysis	5
Multicenter phase II study on the efficacy of an oral nutritional supplement containing eicosapentaenoic acid in advanced gastric cancer patients with cachexia	5
Clinicopathological and genomic features of extrachromosomal DNA in gastric cancer	5
Correction: Ubiquitous mitochondrial creatine kinase promotes the progression of gastric cancer through a JNK-MAPK/JUN/HK2 axis regulated glycolysis	5
Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study	5
Long-term outcomes of a phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumors of the stomach	5
Feasibility of intraoperative pathologic examination for sentinel lymph nodes during sentinel node navigation surgery in early gastric cancer: results of pathologic protocol for SENORITA trial	5
Body weight loss as a prognostic and predictive factor in previously treated patients with metastatic gastric cancer: post hoc analyses of the randomized phase III TAGS trial	5
Hampered CD8 + ILT2 + T cell activation by HLA-G suggests a new immune checkpoint in gastric adenocarcinoma	5
Age is not destiny: what RINDBeRG tells us—and what it does not—about Irinotecan in older adults	5
Dihydrotestosterone-androgen receptor signaling suppresses EBV-positive gastric cancer through DNA demethylation-mediated viral reactivation	5
Short-term outcomes of preoperative chemotherapy with docetaxel, oxaliplatin, and S-1 for gastric cancer with extensive lymph node metastasis (JCOG1704)	5
Inhibition of proprotein convertases activity results in repressed stemness and invasiveness of cancer stem cells in gastric cancer	5
Early stage gastric cancer with unusual sarcomatous component and no recurrence after endoscopic submucosal dissection: a case report	5
Clinical practice guidelines for esophagogastric junction cancer: Upper GI Oncology Summit 2023	5
Correction to: DNA methylation downregulated mir-10b acts as a tumor suppressor in gastric cancer	4
Usefulness of an S-1 dosage formula: an exploratory analysis of randomized clinical trial (JCOG1001)	4
Photodynamic therapy improves the outcome of immune checkpoint inhibitors via remodelling anti-tumour immunity in patients with gastric cancer	4
Diagnostic performance of staging laparoscopy after chemotherapy and the prognostic impact of peritoneal disease resolution in advanced gastric cancer	4
Molecular features and prognostic factors of locally advanced microsatellite instability-high gastric cancer	4
Effect of the number of cycles of docetaxel + S-1 therapy on long-term survival in adjuvant chemotherapy for stage III gastric cancer. A pooled analysis of the OGSG0604 and OGSG1002 trials	4
A nonrandomized controlled trial: long-term outcomes of LATG/LAPG for cStage I gastric cancer: Japan Clinical Oncology Group Study JCOG1401	4
Effects of RAD50 SNP, sodium intake, and H. pylori infection on gastric cancer survival in Korea	4
YAP as a therapeutic target to reverse trastuzumab resistance	4
CEACAM5 and TROP2 define metaplastic and dysplastic transitions in human antral gastric precancerous lesions and tumors	4
Correction: Spatial organization of B lymphocytes and prognosis prediction in patients with gastric cancer	4
Incidence and risk factors of tuberculosis in patients following gastrectomy or endoscopic submucosal dissection: a cohort analysis of country-level data	4
Preclinical toxicological assessment of amido-bridged nucleic acid-modified antisense oligonucleotides targeting synaptotagmin XIII for intra-abdominal treatment of peritoneal metastasis of gastric ca	4
An artificial intelligence system for comprehensive pathologic outcome prediction in early gastric cancer through endoscopic image analysis (with video)	4
Therapeutic value of para-aortic lymph node dissection in gastric cancer with extensive lymph node metastasis: integrated analysis of three phase II trials (JCOG2212A)	4
Direct prediction of genetic aberrations from pathology images in gastric cancer with swarm learning	4
Long-term oncological outcomes of 3D versus 2D laparoscopic gastrectomy for gastric cancer: a randomized clinical trial	4
Classification based on tumor phenotypes enables the novel molecular characterization of esophagogastric junction cancer	4
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study	4
Correction: An artificial intelligence system for comprehensive pathologic outcome prediction in early gastric cancer through endoscopic image analysis (with video)	4
Impact of prophylactic drain placement on intra-abdominal infections after gastrectomy: nationwide inpatient database study in Japan	4
Evaluation of the widths of the mucosal strips in pathological examination of specimens of endoscopic submucosal dissection for early gastric cancer	4
Efficacy and safety of trifluridine/tipiracil plus ramucirumab in comparison with trifluridine/tipiracil monotherapy for patients with advanced gastric cancer–single institutional experience	4
Eligibility criteria in phase 3 randomized controlled trials in gastric cancer	4
Clinicopathological significance of JAK2, STAT3, and STAT4 expression in patients with gastric solid-type poorly differentiated adenocarcinoma: a retrospective study	4
Impact of preoperative prealbumin levels on long-term prognosis in patients with gastric cancer after gastrectomy: a retrospective cohort study	4
Anthracycline chemicals with anthracyclinone structure exert antitumor effects by inhibiting angiogenesis and lymphangiogenesis in a xenografted gastric tumor model	4
Development of the PERI-Gastric (PEritoneal Recurrence Index) and PERI-Gram (Peritoneal Recurrence Index NomoGRAM) for predicting the risk of metachronous peritoneal carcinomatosis after gastrectomy w	4
Lipocalin-2 negatively regulates epithelial–mesenchymal transition through matrix metalloprotease-2 downregulation in gastric cancer	4